Treatment of Progressive MS: Why, Who, When, How
Giancarlo Comi, MD
More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
Prof. Ralf Gold
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
The Diagnostic Challenges of Spinal Cord Lesions in MS
Jiwon Oh, MD, PhD
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Reducing the Burden of MS Treatment
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Multiple Sclerosis Physician Resources
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.